ALDH3A1 and neoplasm: Having established that both ALDH1A1 and ALDH3A1 possess the GSH/DHLA-dependent NAD+-reduction activity, we tested whether or not this activity is responsible for the tumor-promoting effects observed for ALDH1A1/3A1.